TABLE OF CONTENTS
1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 35
1.3 OVERVIEW OF GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET 35
1.4 CURRENCY AND PRICING 37
1.5 LIMITATIONS 37
1.6 MARKETS COVERED 37
2 MARKET SEGMENTATION 40
2.1 MARKETS COVERED 40
2.2 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: GEOGRAPHICAL SCOPE 41
2.3 YEARS CONSIDERED FOR THE STUDY 42
2.4 CURRENCY AND PRICING 42
2.5 DBMR TRIPOD DATA VALIDATION MODEL 43
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.7 DBMR MARKET POSITION GRID 47
2.8 DBMR VENDOR SHARE ANALYSIS 48
2.9 MULTIVARIATE MODELING 49
2.10 PRODUCTS LIFELINE CURVE 49
2.11 SECONDARY SOURCES 50
2.12 ASSUMPTIONS 50
3 MARKET OVERVIEW 51
3.1 DRIVERS 53
3.1.1 RISING POPULATION OF WORKING MOTHERS 53
3.1.2 GROWING INFANT POPULATION 54
3.1.3 INCREASING CASES OF BREAST CANCER 56
3.1.4 RICE PROTEIN BASED INFANT FORMULA IS WIDELY ACCEPTED AS NON-ALLERGIC PRODUCT 56
3.2 RESTRAINT 57
3.2.1 STRINGENT REGULATION 57
3.3 OPPORTUNITIES 58
3.3.1 GROWING ECONOMIES AND DISPOSABLE INCOME IN EMERGING REGIONS 58
3.3.2 INCREASING AWARENESS REGARDING IMPORTANCE OF NUTRITION FOR INFANTS 59
3.4 CHALLENGES 60
3.4.1 HIGH CONTENT OF TOXIC CHEMICALS IN RICE PROTEIN BASED INFANT FORMULA 60
3.4.2 IMPROPER PACKAGING OF BABY FOOD 60
4 EXECUTIVE SUMMARY 61
5 PREMIUM INSIGHTS 65
6 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY PRODUCT TYPE 68
6.1 OVERVIEW 69
6.2 FOLLOW-ON FORMULA 70
6.3 TODDLER FORMULA 71
6.4 STANDARD FORMULA 71
6.5 SPECIAL FORMULA 72
7 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY TYPE 73
7.1 OVERVIEW 74
7.2 UNFORMULATED 75
7.3 FORMULATED 76
7.3.1 VEGETABLES 76
7.3.2 FRUITS 77
7.3.3 CEREAL 77
8 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY FORM 78
8.1 OVERVIEW 79
8.2 NON-GMO 80
8.3 GMO 80
9 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY INFANT AGE 82
9.1 OVERVIEW 83
9.2 6-12 MONTHS 84
9.3 1-3 YEARS 84
9.4 0-6 MONTHS 85
10 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL 86
10.1 OVERVIEW 87
10.2 STORE-BASED RETAILER 88
10.2.1 CONVENIENCE STORES 88
10.2.2 SUPERMARKETS/HYPERMARKETS 89
10.2.3 SPECIALTY STORES 89
10.2.4 GROCERY STORES 89
10.2.5 WHOLESALERS 89
10.3 NON-STORE RETAILER 89
10.3.1 ONLINE 90
10.3.2 VENDING 90
?
11 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY GEOGRAPHY 91
11.1 OVERVIEW 92
11.2 NORTH AMERICA 97
11.2.1 U.S. 104
11.2.2 CANADA 108
11.2.3 MEXICO 112
11.3 EUROPE 116
11.3.1 GERMANY 123
11.3.2 FRANCE 127
11.3.3 U.K. 131
11.3.4 ITALY 135
11.3.5 SPAIN 139
11.3.6 NETHERLANDS 143
11.3.7 POLAND 147
11.3.8 SWEDEN 151
11.3.9 SWITZERLAND 155
11.3.10 BELGIUM 159
11.3.11 DENMARK 163
11.3.12 RUSSIA 167
11.3.13 TURKEY 171
11.3.14 REST OF EUROPE 175
11.4 ASIA-PACIFIC 176
11.4.1 CHINA 183
11.4.2 JAPAN 187
11.4.3 INDIA 191
11.4.4 SOUTH KOREA 195
11.4.5 AUSTRALIA 199
11.4.6 SINGAPORE 203
11.4.7 THAILAND 207
11.4.8 INDONESIA 211
11.4.9 MALAYSIA 215
11.4.10 NEW ZEALAND 219
11.4.11 PHILIPPINES 223
11.4.12 VIETNAM 227
11.4.13 REST OF ASIA-PACIFIC 231
11.5 SOUTH AMERICA 232
11.5.1 BRAZIL 239
11.5.2 ARGENTINA 243
11.5.3 REST OF SOUTH AMERICA 247
11.6 MIDDLE EAST & AFRICA 248
11.6.1 SOUTH AFRICA 255
11.6.2 SAUDI ARABIA 259
11.6.3 UAE 263
11.6.4 KUWAIT 267
11.6.5 OMAN 271
11.6.6 QATAR 275
11.6.7 REST OF MIDDLE EAST & AFRICA 279
12 SWOT & DBMR ANALYSIS 280
12.1 SWOT ANALYSIS 280
12.2 DATA BRIDGE MARKET RESEARCH ANALYSIS 281
13 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, COMPANY LANDSCAPE 282
13.1 COMPANY SHARE ANALYSIS: GLOBAL 282
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 283
13.3 COMPANY SHARE ANALYSIS: EUROPE 284
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 285
13.5 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 286
14 COMPANY PROFILE 287
14.1 LACTALIS INTERNATIONAL 287
14.1.1 COMPANY SNAPSHOT 287
14.1.2 COMPANY SHARE ANALYSIS 287
14.1.3 PRODUCT PORTFOLIO 288
14.1.4 RECENT DEVELOPMENTS 288
14.2 NOVALAC 289
14.2.1 COMPANY SNAPSHOT 289
14.2.2 COMPANY SHARE ANALYSIS 289
14.2.3 PRODUCT PORTFOLIO 290
14.2.4 RECENT DEVELOPMENT 290
14.3 BAYER AG 291
14.3.1 COMPANY SNAPSHOT 291
14.3.2 REVENUE ANALYSIS 291
14.3.3 COMPANY SHARE ANALYSIS 292
14.3.4 PRODUCT PORTFOLIO 292
14.3.5 RECENT DEVELOPMENT 292
14.4 LABORATORIOS ORDESA 293
14.4.1 COMPANY SNAPSHOT 293
14.4.2 COMPANY SHARE ANALYSIS 293
14.4.3 PRODUCT PORTFOLIO 294
14.4.4 RECENT DEVELOPMENT 294
14.5 BIOLAB PHARMA 295
14.5.1 COMPANY SNAPSHOT 295
14.5.2 PRODUCT PORTFOLIO 295
14.5.3 RECENT DEVELOPMENT 295
14.6 KATE FARMS 296
14.6.1 COMPANY SNAPSHOT 296
14.6.2 PRODUCT PORTFOLIO 296
14.6.3 RECENT DEVELOPMENT 296
14.7 LA MANDORLE 297
14.7.1 COMPANY SNAPSHOT 297
14.7.2 PRODUCT PORTFOLIO 297
14.7.3 RECENT DEVELOPMENT 298
14.8 NUCITEC SA DE CV 299
14.8.1 COMPANY SNAPSHOT 299
14.8.2 PRODUCT PORTFOLIO 299
14.8.3 RECENT DEVELOPMENT 300
15 QUESTIONNAIRE 301
16 CONCLUSION 304
17 RELATED REPORTS 305